I don't disagree with anything you say. My caution is that the broader market in general will re-rate the share price once growth is reported and demonstrated perhaps over several quarterlies, not just one. Don't be surprised if that takes some time. This is the ASX, not NASDAQ. As we agree, the only way forward for a company like CRO is to churn earnings into growth in the medium term. Anyone willing to hold for say a two year time frame should (hopefully) do well. What the share price will be by Christmas is of no interest to me. I'm only holding CROO and my intention is to convert them all to heads.
This aligns with AFs desire that CRO becomes a portfolio stock. That isn't going to happen for a couple of years IMHO. I use Wizr (WZR) as a comparison as I have held for a couple of years now. It's a consumer finance fintech that has put in revenue growth of 94% (FY19), 137% (FY20), 125% (FY21) and yet the broader market is still fairly disinterested in it because it is pre-profit. What WZR and CRO have in common is that they are both reboots of previous less successful listed tech businesses.
Any professional investor who wants to accumulate will probably do well over the remainder of this calendar year in keeping the share price down around these levels or lower to frustrate the impatient and those thinking the share price is going to hit 10c by Christmas into selling.
The share price put in a lower high last week before retracing. The weekly chart shows a gravestone doji candlestick for last week. The chances are of a further retracement over coming days.
I could be wrong. We could be one announcement away from a break-out. But again, I use WZR as a comparison. Good announcements buoy the retail holders and traders but in time the share price drifts down after a run up. As stated above, it really is irrelevant to me.
(20min delay)